This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.
Inclusion Criteria:
-Japanese patients living in Japan with a history of allergic conjunctivitis.
Exclusion Criteria:
Tokyo, Japan